|
|
Volumn 27, Issue 3, 2001, Pages 260-265
|
|
A pilot trial of indinavir, ritonavir, didanosine, and lamivudine in a once-daily four-drug regimen for HIV infection
|
|
Author keywords
Didanosine; HIV; Indinavir; Lamivudine; Once daily; Pharmacokinetics; Ritonavir
|
|
Indexed keywords
AMINOTRANSFERASE;
AMYLASE;
ANTIRETROVIRUS AGENT;
BILIRUBIN;
CHOLESTEROL;
DIDANOSINE;
EFAVIRENZ;
GLUCOSE;
INDINAVIR;
LAMIVUDINE;
LIPID;
RITONAVIR;
SAQUINAVIR;
TRIACYLGLYCEROL;
TRIACYLGLYCEROL LIPASE;
VIRUS RNA;
ADULT;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DIARRHEA;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
GENOTYPE;
HEMATURIA;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
LYMPHOCYTE COUNT;
MALE;
NAUSEA;
PARESTHESIA;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
TRIACYLGLYCEROL BLOOD LEVEL;
VIRUS LOAD;
|
|
EID: 0035393638
PISSN: 15254135
EISSN: None
Source Type: Journal
DOI: 10.1097/00126334-200107010-00007 Document Type: Article |
|
Times cited : (26)
|
|
References (9)
|
